Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 4 de 4
Filtrar
1.
Am J Perinatol ; 2022 Jul 10.
Artículo en Inglés | MEDLINE | ID: mdl-35815572

RESUMEN

OBJECTIVE: Oxygen saturation profiles generated by pulse oximetry are used as a clinical tool in the neonatal intensive care unit (NICU). There is limited evidence on normal oxygen saturation profile values in term infants. This study aimed to determine oxygen saturation profiles over an 8-hour monitoring period among healthy term neonates between 24 and 48 hours after birth. STUDY DESIGN: A prospective cohort study of healthy term neonates born at 37 to 41 weeks of gestation. Preductal oxygen saturations were continuously monitored for an 8-hour period between 24 and 48 hours of life using pulse oximetry. Oxygen profile histograms were recorded for analysis. The average percent oxygen saturation (SpO2) was measured over the entire study duration for each neonate and was characterized as the fraction of time of their SpO2 reading was in each of five intervals: ≤80, 81 to 84, 85 to 89, 90 to 94, and 95 to 100%. RESULTS: Seventy-five neonates were included in the study. Median SpO2 was 95.4%. Percentage time spent in each of the five SpO2 intervals was as follows: 0.07 (≤80), 0.15 (81-84), 0.88 (85-89), 26.9 (90-94), and 67.3% (95-100%). Eighteen infants (24%) spent the highest percentage of time in SpO2 of 90 to 94%. CONCLUSION: This study provides reference ranges for oxygen profiles in healthy term neonates during 24 to 48 hours of life. Nearly one-quarter of newborns spent the highest percentage of time in SpO2 of 90 to 94%. This data is important when interpreting oxygen saturation profiles of term neonates admitted to the NICU. KEY POINTS: · This study provide reference ranges for oxygen profiles in healthy term neonates during 24 to 48 hours.. · Median SpO2 was 95.4%.. · Nearly one quarter of newborns spent the highest percentage of time in SpO2 of 90 to 94%..

2.
WMJ ; 110(2): 63-7, 2011 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-21560559

RESUMEN

OBJECTIVE: Determine the influenza immunization practices of Wisconsin pediatricians in response to evolving influenza prevention strategy in the United States. DESIGN: Two hundred fifty members of the Wisconsin Chapter of the American Academy of Pediatrics were surveyed prior to the 2004-2005 influenza season about their expectations for implementing the latest and future influenza vaccination recommendations for children and their use of trivalent inactivated influenza vaccines free of thimerosal as a preservative. RESULTS: Ninety-two percent of respondents expected to vaccinate most medically high-risk children against influenza, but only 53% would recommend influenza vaccine for most of their household contacts. Although 57% planned to vaccinate most healthy children ages 6 months to 23 months, just 27% thought the majority of household contacts of healthy infants under 23 months of age would be vaccinated. Fewer than 24% favored universal influenza vaccination for the majority of healthy school-aged children. Seventy percent had little or no concern about recommending thimerosal-containing influenza vaccines, but 60% agreed or strongly agreed thimerosal-free vaccine availability would increase parental acceptance of vaccinating their children. CONCLUSION: Although Wisconsin pediatricians are aware of the importance of preventing influenza disease in children, barriers to universal influenza vaccination of children and key household contacts remain.


Asunto(s)
Actitud del Personal de Salud , Vacunas contra la Influenza , Gripe Humana/prevención & control , Pediatría/normas , Médicos/psicología , Pautas de la Práctica en Medicina/estadística & datos numéricos , Adolescente , Distribución de Chi-Cuadrado , Niño , Preescolar , Humanos , Lactante , Estadísticas no Paramétricas , Encuestas y Cuestionarios
3.
J Pediatr ; 153(1): 133-6, 2008 Jul.
Artículo en Inglés | MEDLINE | ID: mdl-18571551

RESUMEN

We measured cord blood zinc protoporphyrin/heme (ZnPP/H) and plasma ferritin in healthy African-American and Hispanic newborns, matched by gestation with Caucasian newborns. In these at-risk minorities, cord ZnPP/H was higher and plasma ferritin lower, supporting the feasibility of screening newborns at-risk for iron deficiency at birth.


Asunto(s)
Anemia Ferropénica/diagnóstico , Ferritinas/sangre , Sangre Fetal/metabolismo , Hemo/biosíntesis , Deficiencias de Hierro , Protoporfirinas/sangre , Negro o Afroamericano , Anemia Ferropénica/etnología , Proteína C-Reactiva/biosíntesis , Estudios de Casos y Controles , Femenino , Hispánicos o Latinos , Humanos , Recién Nacido , Masculino , Tamizaje Neonatal , Riesgo
4.
Pediatr Res ; 64(1): 63-7, 2008 Jul.
Artículo en Inglés | MEDLINE | ID: mdl-18360311

RESUMEN

In infants and children, elevated whole blood zinc protoporphyrin/heme (ZnPP/H) measures iron-deficient (ID) erythropoiesis. Because immature erythrocytes are less dense than mature erythrocytes, we hypothesized that the sensitivity of ZnPP/H is improved if measured in the least dense cells. Blood was collected from control suckling, mildly and severely ID suckling rats. Cord blood was collected after uncomplicated pregnancies (control), diabetic pregnancies (severe ID) and after pregnancies at-risk for iron deficiency (mild ID). ZnPP/H was measured before and after a two-step density centrifugation to obtain the lightest 6.25% of erythrocyte (top fraction). The difference between whole blood and top fraction was defined as DeltaZnPP/H. In rats, although the whole or top ZnPP/H differed by postnatal age, DeltaZnPP/H was greatest after the interval with least body iron accrual. In either rats or humans with mild ID, whole blood ZnPP/H was similar to, but DeltaZnPP/H was greater than controls. In rats and newborn humans, DeltaZnPP/H is more sensitive than whole blood ZnPP/H in identifying conditions associated with impaired erythrocyte iron delivery and may become a useful tool in measuring erythrocyte iron incorporation in early development.


Asunto(s)
Anemia Ferropénica/diagnóstico , Anemia Neonatal/diagnóstico , Eritropoyesis , Sangre Fetal/metabolismo , Hemo/metabolismo , Hierro/metabolismo , Protoporfirinas/sangre , Reticulocitos/metabolismo , Factores de Edad , Anemia Ferropénica/sangre , Anemia Ferropénica/etiología , Anemia Neonatal/sangre , Anemia Neonatal/etiología , Animales , Animales Recién Nacidos , Animales Lactantes , Biomarcadores/sangre , Femenino , Humanos , Recién Nacido , Valor Predictivo de las Pruebas , Embarazo , Embarazo en Diabéticas/sangre , Ratas , Ratas Sprague-Dawley , Reproducibilidad de los Resultados , Índice de Severidad de la Enfermedad
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA